344 material Form 8-K filings that 303 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On August 14, 2024, Installed Building Products entered into a share repurchase agreement to buy 100,000 shares of its common stock from PJAM IBP Holdings, an Edwards family entity, in a privately negotiated deal under its previously announced buyback program. The purchase totals $20.7 million, funded from cash on hand, and was approved by the board and audit committee because CEO Jeff Edwards has beneficial ownership of the shares.
Price of $206.90 per share, a 3% discount to the August 13, 2024 last reported sale price
Total purchase price of $20,690,000, funded from the company's cash on hand
Seller is PJAM IBP Holdings, Inc.; CEO Jeff Edwards has beneficial ownership of the shares
Approved by the Board of Directors and Audit Committee; agreement filed as Exhibit 10.1
Waters Corporation increased its board from 9 to 10 members and appointed Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International, effective August 14, 2024. Her compensation includes an initial equity grant valued at $91,666 and a prorated cash retainer of $54,130 through the 2025 annual meeting, which shareholders will see in the company's disclosures.
Board expanded from 9 to 10 members on August 13, 2024; Knight's appointment is effective August 14, 2024.
Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International.
Initial equity grant valued at $91,666, split 50% restricted stock and 50% non-qualified stock options, vesting on the first anniversary of grant.
Prorated cash retainer of $54,130 for service until the 2025 annual meeting; the Board determined she is independent under NYSE standards.
DaVita completed a $1.0 billion private offering of 6.875% senior notes due 2032 on August 13, 2024, and entered into a credit agreement amendment adding a $1.1 billion incremental term loan maturing April 28, 2028. The company said net proceeds of about $2,080.7 million were used to repay roughly $950.0 million of Tranche B-1 term loans and $60.0 million of revolving loans, with $350.0 million more of revolving loans planned for repayment. The refinancing changes the company's debt mix and interest costs, but the filing does not state the effect on total debt.
$1.0 billion of 6.875% senior notes due September 1, 2032, issued in a private offering completed August 13, 2024
$1.1 billion incremental Term Loan A-1 facility maturing April 28, 2028, with quarterly amortization starting September 30, 2024
Net proceeds of about $2,080.7 million used to repay roughly $950.0 million of 2026 term loans and $60.0 million of revolving loans
Remaining proceeds planned for $350.0 million of revolving loan repayment and general corporate purposes, including possible share repurchases
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.